Perspective Therapeutics CATX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's cash ratio?
- Perspective Therapeutics (CATX) reported cash ratio of 1.7× in Q1 2026.
- How has Perspective Therapeutics's cash ratio changed year-over-year?
- Perspective Therapeutics's cash ratio decreased by 51.1% year-over-year, from 3.5× to 1.7×.
- What is the long-term trend for Perspective Therapeutics's cash ratio?
- Over 5 years (2020 to 2025), Perspective Therapeutics's cash ratio has grown at a -31.7% compound annual growth rate (CAGR), from 7.2× to 1.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.